首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Development and validation of an ion chromatography method for the determination of phosphate-binding of lanthanum carbonate.
【24h】

Development and validation of an ion chromatography method for the determination of phosphate-binding of lanthanum carbonate.

机译:离子色谱法测定碳酸镧中磷酸根的方法的建立和验证。

获取原文
获取原文并翻译 | 示例
           

摘要

Lanthanum carbonate is indicated to reduce serum phosphate in patients with end stage renal disease (ESRD). When given orally, lanthanum carbonate dissociates in the acid environment of the upper gastrointestinal tract to release lanthanum ions. The free lanthanum ions bind with dietary phosphate released from food during digestion to form highly insoluble lanthanum-phosphate complexes which prevent the absorption of phosphate, consequently reduce the serum phosphate. In order to evaluate the in vitro binding capacity of lanthanum carbonate, a simple and efficient ion chromatography (IC) method was developed and validated for determination of phosphate across the pH range encountered in the gastrointestinal tract. Chromatographic separation was achieved on a Dionex ICS-2000 IC system using a Dionex AS16, IonPac (4mmx250mm) analytical column and Dionex AG16, IonPac (4mmx50mm) guard column. Column temperature was maintained at 30 degrees C. Injection volume was 10microL. The compounds were eluted isocratically at a flow rate of 1mL/min and detected by suppressed conductivity. The analytical method was validated according to USP Category I requirements. The validation characteristics included accuracy, precision, quantification limit, linearity, and stability. The intra-day accuracy ranged from 89% to 103% for the solutions of pH 1.2-6.8. The intra-day precision (RSD) ranged from 0.6% to 3.7% for the solutions of pH 1.2-6.8. The analytical range was linear from 2 to 200ppm (mg/L). The R(2) ranged from 0.9998 to 1.0. This method was found to be simple, robust, sensitive, specific, and accurate. It has been successfully applied for determination of phosphate binding to lanthanum carbonate over the human gastrointestinal pH range at different time-points (from 0.5 to 24h).
机译:碳酸镧可降低患有终末期肾病(ESRD)的患者的血清磷酸盐。口服时,碳酸镧在上消化道的酸性环境中解离,释放出镧离子。游离的镧离子与消化过程中从食物中释放出的膳食磷酸盐结合,形成高度不溶的镧-磷酸盐复合物,从而阻止了磷酸盐的吸收,从而降低了血清中的磷酸盐。为了评估碳酸镧的体外结合能力,开发了一种简单有效的离子色谱(IC)方法,并验证了其在胃肠道所遇到的pH范围内测定磷酸盐的有效性。使用Dionex AS16 IonPac(4mmx250mm)分析柱和Dionex AG16 IonPac(4mmx50mm)保护柱,在Dionex ICS-2000 IC系统上进行色谱分离。柱温保持在30℃。进样体积为10μL。化合物以1mL / min的流速等度洗脱,并通过抑制电导率进行检测。该分析方法已根据USP I类要求进行了验证。验证特征包括准确性,精确度,定量限,线性和稳定性。对于pH 1.2-6.8的溶液,日内准确性在89%至103%的范围内。对于pH 1.2-6.8的溶液,日内精度(RSD)为0.6%至3.7%。分析范围为2至200ppm(mg / L)的线性范围。 R(2)范围从0.9998到1.0。发现该方法简单,可靠,灵敏,特异且准确。它已成功地用于测定人体胃肠道pH范围内不同时间点(0.5至24h)的磷酸盐与碳酸镧的结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号